Literature DB >> 22925336

Association between hTERT activation by HPV E6 proteins and oncogenic risk.

Koenraad Van Doorslaer1, Robert D Burk.   

Abstract

Expression of activated telomerase and subversion of the p16/pRb pathway is sufficient and essential for the in vitro immortalization of primary keratinocytes. Most cancers-including cervical carcinoma-over-express hTERT, the catalytic domain of the telomerase complex. Only a limited set of viruses within the Alphapapillomavirus genus are oncogenic. The viral functions responsible for this distinction are not well understood. The human papillomavirus type 16 E6 protein activates the hTERT promoter. We used a luciferase-based assay to test the ability of 29 viral types, representing all current species within the Alphapapillomavirus genus, to activate the hTERT promoter. We show that oncogenic types specifically activate the hTERT promoter, while non-oncogenic types do not. Statistical analysis supports the notion that activation of the hTERT promoter is uniquely associated with oncogenic types, independent of evolutionary relationships. This finding begins to shed light on the viral phenotypes correlated with oncogenic potential.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22925336      PMCID: PMC3449093          DOI: 10.1016/j.virol.2012.08.006

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  40 in total

1.  Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites.

Authors:  S T Oh; S Kyo; L A Laimins
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  MrBayes 3: Bayesian phylogenetic inference under mixed models.

Authors:  Fredrik Ronquist; John P Huelsenbeck
Journal:  Bioinformatics       Date:  2003-08-12       Impact factor: 6.937

Review 3.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

4.  E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc.

Authors:  L Gewin; D A Galloway
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  AWTY (are we there yet?): a system for graphical exploration of MCMC convergence in Bayesian phylogenetics.

Authors:  Johan A A Nylander; James C Wilgenbusch; Dan L Warren; David L Swofford
Journal:  Bioinformatics       Date:  2007-08-30       Impact factor: 6.937

6.  Amplification of the telomerase reverse transcriptase (hTERT) gene in cervical carcinomas.

Authors:  Anju Zhang; Chengyun Zheng; Mi Hou; Charlotta Lindvall; Keng-Ling Wallin; Tord Angström; Xiaoyan Yang; Ann-Cathrin Hellström; Elisabeth Blennow; Magnus Björkholm; Anders Zetterberg; Astrid Gruber; Dawei Xu
Journal:  Genes Chromosomes Cancer       Date:  2002-07       Impact factor: 5.006

Review 7.  Evolution of human papillomavirus carcinogenicity.

Authors:  Koenraad Van Doorslaer; Robert D Burk
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

8.  Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein.

Authors:  T Veldman; I Horikawa; J C Barrett; R Schlegel
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

9.  E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway.

Authors:  S N Boyer; D E Wazer; V Band
Journal:  Cancer Res       Date:  1996-10-15       Impact factor: 12.701

10.  Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells.

Authors:  T Kiyono; S A Foster; J I Koop; J K McDougall; D A Galloway; A J Klingelhutz
Journal:  Nature       Date:  1998-11-05       Impact factor: 49.962

View more
  25 in total

Review 1.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

2.  Differential in vitro immortalization capacity of eleven (probable) [corrected] high-risk human papillomavirus types.

Authors:  Denise M Schütze; Peter J F Snijders; Leontien Bosch; Duco Kramer; Chris J L M Meijer; Renske D M Steenbergen
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

3.  Longitudinal assessment of DNA methylation changes during HPVE6E7-induced immortalization of primary keratinocytes.

Authors:  Denise M Schütze; Jan M Kooter; Saskia M Wilting; Chris J L M Meijer; Wim Quint; Peter J F Snijders; Renske D M Steenbergen
Journal:  Epigenetics       Date:  2015-01-23       Impact factor: 4.528

4.  Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation.

Authors:  Marcel Chris Conrady; Irina Suarez; Gergö Gogl; Desiree Isabella Frecot; Anna Bonhoure; Camille Kostmann; Alexandra Cousido-Siah; André Mitschler; JiaWen Lim; Murielle Masson; Thomas Iftner; Frank Stubenrauch; Gilles Travé; Claudia Simon
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

5.  Association Between Type-specific HPV Infections and hTERT DNA Methylation in Patients with Invasive Cervical Cancer.

Authors:  Mónica Molano; Pablo Moreno-Acosta; Nicolás Morales; Marcela Burgos; Lina Buitrago; Oscar Gamboa; Rayner Alvarez; Suzanne M Garland; Sepehr N Tabrizi; Renske D M Steenbergen; Juan Carlos Mejía
Journal:  Cancer Genomics Proteomics       Date:  2016 11-12       Impact factor: 4.069

6.  hTERT Protein Expression in Cytoplasm and Nucleus and its Association With HPV Infection in Patients With Cervical Cancer.

Authors:  Pablo Moreno-Acosta; MÓnica Molano; Nicolas Morales; Jinneth Acosta; Cristian GonzÁlez-Prieto; Diana Mayorga; Lina Buitrago; Oscar Gamboa; Juan Carlos MejÍa; July Castro; Alfredo Romero-Rojas; Sophie Espenel; Gerald L Murray; Suzanne M Garland; Alexis Vallard; Nicolas MagnÉ
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

7.  TERT promoter hot spot mutations are frequent in Indian cervical and oral squamous cell carcinomas.

Authors:  Vilvanathan Vinothkumar; Ganesan Arunkumar; Sundaramoorthy Revathidevi; Kanagaraj Arun; Mayakannan Manikandan; Arunagiri Kuha Deva Magendhra Rao; Kottayasamy Seenivasagam Rajkumar; Chandrasekar Ajay; Ramamurthy Rajaraman; Rajendren Ramani; Avaniyapuram Kannan Murugan; Arasambattu Kannan Munirajan
Journal:  Tumour Biol       Date:  2015-12-23

Review 8.  Idiosyncrasies of Viral Noncoding RNAs Provide Insights into Host Cell Biology.

Authors:  Johanna B Withers; Vanessa Mondol; Paulina Pawlica; Nicolle A Rosa-Mercado; Kazimierz T Tycowski; Salehe Ghasempur; Seyed F Torabi; Joan A Steitz
Journal:  Annu Rev Virol       Date:  2019-04-30       Impact factor: 10.431

Review 9.  The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation.

Authors:  James A Scarth; Molly R Patterson; Ethan L Morgan; Andrew Macdonald
Journal:  J Gen Virol       Date:  2021-01-11       Impact factor: 3.891

10.  Structural insights into a wildtype domain of the oncoprotein E6 and its interaction with a PDZ domain.

Authors:  André Mischo; Oliver Ohlenschläger; Peter Hortschansky; Ramadurai Ramachandran; Matthias Görlach
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.